Summary.-A statistical model has been proposed in an attempt to integrate coincidental (or Analysis in terms of the model showed a 296-fold increase in risk for a second primary tumour in the contralateral breast in a series of nearly 22,000 breast -cancer patients. The corresponding risks for 3 main age-ranges (at the time of diagnosis of the first primary) were 5-3 (ages 15-44), 3-3 (45-59) and 1-5 (60 +). In addition, a maximal risk of 5-0-fold was observed in the series as a whole during the third year after the diagnosis of the first primary.
IN A PREVIOUS REPORT (Prior & Waterhouse, 1978 ) the incidence of second primary tumours in the contralateral breast was evaluated for a series of nearly 22,000 breast-cancer patients registered at the Birmingham Regional Cancer Registry over a period of 28 years. Two methods of assessment were described: Method 1, which included all coincidental (or synchronous) diagnoses in the observed number of tumours, showed a 3-fold increase in risk of a second primary; when coincidental diagnoses were excluded from the analysis (Method 2) the relative risk was found to be [2] [3] [4] times that of the general population for a first primary.
The small difference in overall risk between the two methods might not be of immediate clinical importance. Nevertheless, the cluster of coincidental tumours (23% of total observed in the series) could be of aetiological significance, and it also presented a statistical problem.
Points of difference can be found in the literature in both the definition and statistical treatment of coincidental tumour. They have been described variously as tumours diagnosed (i) during admission for the first primary or (ii) within varying intervals from the first primary, namely, 1, 6 or 12 months. For statistical purposes they have been: (i) included in the analysis (Robbins & Berg, 1974) ; (ii) included on an arbitrary basis (Berg, 1967) ; (iii) assessed separately and excluded from the final comparisons between observed and expected numbers (Schottenfeld & Berg, 1971; Veronesi et al., 1974) ; (iv) eliminated automatically with all other cases diagnosed within 5 years of the first primary (Greenberg, 1963; Schoenberg et al., 1969) ; and (v) deliberately excluded (Schoenberg & Christine, 1974) on the grounds that it was impossible to calculate an expected number for this group. These differing approaches to coincidental tumours, in addition to invalidating comparisons between surveys, suggest that there is some debate concerning the validity of their inclusion in an analysis.
For the purposes of the Birmingham Survey, coincidental tumours were defined as those diagnosed at the same time as or within one month of the first primary. The effect of their inclusion and exclusion on the statistical analysis has been explored. It was considered, however, that Method 1, on the one hand, although implicitly acknowledging that coincidental tumours formed a valid part of the observed number, made no allowance for their differing pattern of presentation from that of first primaries; on the other hand, Method 2 might underestimate the true incidence of second primary tumours. A third method is therefore presented here in an attempt to resolve the statistical dilemma. Although the method was developed primarily within the context of the bilateral breast survey, the intention was that it should be of general applicability to analyses for any pair of sites. The rationale for this methodological approach is that, when population-based Registry data are used, coincidental tumours, which are all new diagnoses, form an integral part of the pattern of tumour incidence.
METHOD
Theoretical basis.-The conventional approach to analysis (Method 1) is based on a null hypothesis that the diagnoses of first and second primary tumours are independent events. On this basis, incidence rates for first primaries are used to compute the expected number of second primary tumours, the implication being that the pattern of development and diagnosis is the same for both tumours.
A representation of the development of a first primary in breast is given in Fig. 1 : following the malignant change at A, the tumour would be detectable but nonsymptomatic at B, symptomatic at C and would come to clinical diagnosis at D, a point in time which is determined by the patient herself seeking medical aid.
Tumour incidence rates are, therefore, based on "patient-dependent" diagnoses. The method was developed, therefore, to recompute the expected number of second primary tumours on the basis of a predicted time of diagnosis, which allowed for the anticipatory effect, in contrast to the conventional method, which assumed complete independence between the tumours.
The effects of anticipatory diagnosis.-(i) The maximum yield of second primary tumours will be obtained when the patient presents with the first primary (assuming a detailed examination of every patient). The number of tumours so found will be dependent on the duration of the preclinical period.
(ii) Anticipatory diagnosis produces an apparent deficit of tumours later in the period of observation. In the simplest situation, for instance, if all tumours expected to occur during the first year were diagnosed coincidentally, in the absence of any further clinical follow-up, no more tumours would present until the second vear.
(iii) Anticipatory diagnosis leads to an increase in the absolute number of observed second primaries, an effect which is due to mortality from the first primaries. If, for example, conventional analysis gave an expectation of 100 tumours which increased to 115 on recomputation, the implication would be that in the absence of repeated clinical examinations, 15 patients would have died with detectable but undiagnosed second primary tumours.
The increased number of tumours does not, however, imply an increase in the fundamental risk, i.e. the null hypothesis is not invalidated.
Practical approach. for (i) duration of the preclinical period and (ii) the duration of clinical follow-up in order to make allowance for the effects of anticipatory diagnosis. An estimated value of 16 months had previously been reported for the preclinical period (Prior, 1974) All that remains to complete the analysis is to determine the pattern of presentation of the remaining MUT. If the interval between follow-up examinations remains less than the preclinical period, the full complement of 12 MUT should, theoretically, be diagnosed each year until the patients are discharged from further attendance. If all patients were discharged at the same point in time, there would be an interval, of the order of the duration of the preclinical period, when no further tumours would present, after which interval the more usual "patientdependent" pattern of diagnosis would be resumed. In practice no such hiatus occurs because, for several reasons, the reversion from clinician-to patient-dependent diagnosis is a gradual process which decreases the preclinical period. The result is that fewer than 12 IIUT are diagnosed in each succeeding year. Taking an end-point of 5 years for clinical examination, a total of 60 MUT would be "expected" during the period, 17 of which would be diagnosed at D, leaving 43 to be distributed over the next 5 years.
In Fig. 3 MUT= 1 x (number of patients x age-12 specific incidence rate). For a preclinical period >12 months, such as was found for breast, an additional value must be computed substituting (age+1) in the above equation.
RESULTS

Age at first primary diagnosis
The result of the analysis in terms of age at first primary is given in Table I , and it can be compared with those for Method 1 (Table I) and Method 2 (Table  III) in the previous report (Prior & Waterhouse, 1978) .
Analysis in terms of the model showed that there was a highly significant (P< 0 001) excess of second primary tumours for all patients diagnosed with a first primary before the age of 60. Between the ages of 60 and 74 the level of significance was more variable. After the age of 75 the observed number (22) was not significantly different from the expected number (21-3).
Except for age groups 20-24 and 25-29, the relative risk is lower at each age than that obtained with Method 1, although the level of significance has not altered except for age group 85-89, which had previously shown an excess of borderline significance (P < 0.05).
In terms of the 3 age ranges, relative risk was shown, again, to decrease with increasing age at first primary, and although the values were marginally lower than those obtained by Method 1, all 3 remained highly significant (P < 0-001).
Interval between diagnoses
Observed numbers of tumours are shown in Fig. 4 , in comparison with expected numbers predicted from the model. For coincidental tumours, the expectation was 43-82, where 93 were observed, and for the whole of the first year the corresponding values were 63-27 and 146.
Over the first 5 years the pattern of expectation diverges from the linear effect shown in Fig. 2 of the previous report, and although there is an abrupt rise at Year 6 this is, in fact, matched by a corresponding rise in the observed number.
In Fig. 4 the relative risk over the same period is seen to rise to a peak at 3 years after the diagnosis of the first primary. After 5 years the pattern of observed and expected numbers was the same as that given in Method 1.
Comparison of the three methods was demonstrated. Anticipative diagnosis has a maximal effect at first primary diagnosis, when every patient is assumed to undergo detailed examination, but with regular surveillance, a residual effect operates for several years. If every patient were to be examined at, say, yearly intervals that is, an interval less than the duration of the preclinical period-all second primaries, would, theoretically, be discovered in the preclinical phase. In practice this does not happen, because either (i) patients are discharged from hospital attendance for follow-up because they are considered to be well enough or perhaps because they may be too old or infirm to attend, or (ii) the interval between examinations increases because of missed or delayed appointments.
We consider that the concept of the monthly unit tumour (MUT) is apt when working in the context of numbers of tumours, and it is useful both in visualizing the clinical situation and in facilitating computation by allowing manipulation within the framework of an existing method of analysis.
So many factors affect the presentation of tumours after the first diagnosis that it has not been possible to substantiate quantitatively the pattern of decline in the preclinical period. However, after many simulations with the model, it has been concluded that the peak in risk at 3 years is not artefactual (i.e. is not a consequence of the model) and that the linear approach gives a more acceptable pattern of risk than, say, a decline of logarithmic form.
Taking the cut-off point for hospital attendance at 5 years was a compromise, because clinical practice and patient reaction varied widely for follow-up procedure. Breast, too, poses a special problem in that the contralateral breast is easily examined without causing undue anxiety in the patient, with the result that surveillance for this site is greater than that for other possible second primary sites.
The preclinical period, in this context, (Bross et al., 1968) which was a hypothetical value based on the assumption of logarithmic growth of tumours. Several hypotheses concerning the level of risk at first examination were investigated, and an extreme evaluation, assuming an age-differential pattern, is given in Table IV (Qualheim, 1957) 54% of breasts removed were found 43 to have multiple foci of malignant transformation, and in another report (Bloom, 1968) the change was considered to be almost certainly bilateral. This would suggest that not all malignant foci progress to clinical cancer, either because they are being held in check by the immune system or because of slow growth, or, even, because they may spontaneously regress, but once one focus has progressed to a critical size in relation to the state of immune surveillance, it may be that a second focus can break away from homoeostatic control and come to diagnosis at an interval from the first primary.
However, another common point in time could be diagnosis of (and possibly treatment to) the first primary, a time which might again represent a period of immune stress. A short period of immune depression has been shown to occur after major surgery (Cochran et al., 1972) and radiotherapy also has come under close scrutiny for the same reason (Bond, 1967) . Although the surgical effect was transitory (6-22 days) and the effect of radiotherapy localized, they may be sufficient to allow already transformed cells to escape from control and proceed to express their malignant potential. The cause of the peak is not clear, but it would appear from our results that its effect on risk is more pronounced in younger women.
Although the data from the bilateral breast survey have been used here to present the model, the effect of anticipatory diagnosis is a common problem of many epidemiological investigations in which clinical intervention for one condition influences the presentation of a second. Evaluation of associations between cancer and other diseases or between nonmalignant conditions, for instance, would require similar adjustments. The model is, perhaps, only a simple representation of a complex situation, but it could be refined if more detailed information were available. Nevertheless with such large numbers some generalization is acceptable. Use of the model for analyses of other site pairs will, it is hoped, provide further justification for an approach which allows the use of all available information, thus avoiding the need to make arbitrary exclusions.
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